[Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
Roentgenography of the cranium, ribs, vertebral column, pelvis and scintigraphy of the skeleton were performed every 3-4 mos in 39 patients with breast cancer metastases to the bones. Criteria of therapeutic efficacy were the following: a complete therapeutic effect, a partial therapeutic effect, stabilization and progression. In osteolytic metastases a complete therapeutic effect was obtained in 72% of the cases. Sixteen patients have been in remission during 16-36 mos.
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005069:Evaluation Studies as Topic / Q000379:methods; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged
D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Kriterii otsenki éffektivnosti lecheniia pri metastazakh raka molochnoĭ zhelezy v kosti.